Pelthos Therapeutics Inc.
PTHS
$23.06
-$0.14-0.60%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -33.41% | -370.83% | -75.28% | -2.16% | -13.62% |
| Total Depreciation and Amortization | 6.57% | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -100.00% | -99.94% | 74.84% | 23.95% | 630.77% |
| Total Other Non-Cash Items | 278.02% | 1,077.92% | -14.88% | -8.34% | 243.04% |
| Change in Net Operating Assets | 16.21% | -307.67% | 220.84% | 16.22% | -51.94% |
| Cash from Operations | 59.03% | -3,312.82% | 29.27% | 5.66% | -277.04% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -386.06% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -389.64% | -- | -- | -- | -- |
| Total Debt Issued | 26,220.59% | -81.87% | 50.00% | 262.34% | 82.84% |
| Total Debt Repaid | 100.00% | -- | -- | -- | 100.00% |
| Issuance of Common Stock | 42.35% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -100.00% | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 199.33% |
| Cash from Financing | -32.49% | 7,017.87% | 50.00% | 447.22% | 92.59% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -73.44% | 19,786.96% | 81.13% | 48.50% | 35.46% |